MARABio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $19.1M

  • Investors
  • 3

MARABio General Information

Description

Provider of maternal autoantibody-related autism testing intended to determine the risk of autism spectrum disorder (ASD). The company develops a precision technology that is capable of identifying an unusual and distinctive cluster of antibodies that are directed against proteins in the developing brain of mothers whose children are diagnosed with ASD, enabling mothers to initiate specific beneficial behavioral therapies much earlier if their children exhibit signs of developmental delay.

Contact Information

Website
www.marabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 26 South Rio Grande Street
  • Suite 2072
  • Salt Lake City, UT 84101
  • United States
+1 (801)
Primary Industry
Clinics/Outpatient Services
Vertical(s)
Life Sciences
Corporate Office
  • 26 South Rio Grande Street
  • Suite 2072
  • Salt Lake City, UT 84101
  • United States
+1 (801)

MARABio Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MARABio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 07-Oct-2024 $19.1M Completed Generating Revenue
1. Later Stage VC (Series A) 10-Mar-2022 Completed Startup
To view MARABio’s complete valuation and funding history, request access »

MARABio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-2
To view MARABio’s complete cap table history, request access »

MARABio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of maternal autoantibody-related autism testing intended to determine the risk of autism spectrum disorder (ASD
Clinics/Outpatient Services
Salt Lake City, UT
10 As of 2024

North Brunswick, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MARABio Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LinusBio Venture Capital-Backed North Brunswick, NJ
You’re viewing 1 of 1 competitors. Get the full list »

MARABio Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

MARABio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3190526-A1 Methods for reducing maternal autoantibodies Pending 24-Aug-2020
AU-2021333562-A1 Methods for reducing maternal autoantibodies Pending 24-Aug-2020
EP-4200331-A1 Methods for reducing maternal autoantibodies Pending 24-Aug-2020
US-20240228623-A1 Methods for reducing maternal autoantibodies Pending 24-Aug-2020
EP-4200331-A4 Methods for reducing maternal autoantibodies Pending 24-Aug-2020 C07K16/283
To view MARABio’s complete patent history, request access »

MARABio Executive Team (3)

Name Title Board Seat
Michael Paul Ph.D Chief Executive Officer, President & Board Member
Judy Van de Water Ph.D Founder & Chief Science Advisor
Richard Minicus Chief Financial Advisor
To view MARABio’s complete executive team members history, request access »

MARABio Board Members (9)

Name Representing Role Since
Charles Gardner Self Board Member
Craig Nemiroff Self Board Member
Gail Page Self Board Member
James Woody Ph.D Self Vice Chairman
Marnin Kligfeld Ph.D Self Chairman
You’re viewing 5 of 9 board members. Get the full list »

MARABio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MARABio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
MAK Capital Hedge Fund Minority
AIF Venture Capital Minority
Moai Capital Venture Capital Minority
To view MARABio’s complete investors history, request access »

Ready to get started?

Request a free trial

MARABio FAQs

  • When was MARABio founded?

    MARABio was founded in 2016.

  • Who is the founder of MARABio?

    Judy Van de Water Ph.D is the founder of MARABio.

  • Who is the CEO of MARABio?

    Michael Paul Ph.D is the CEO of MARABio.

  • Where is MARABio headquartered?

    MARABio is headquartered in Salt Lake City, UT.

  • What is the size of MARABio?

    MARABio has 10 total employees.

  • What industry is MARABio in?

    MARABio’s primary industry is Clinics/Outpatient Services.

  • Is MARABio a private or public company?

    MARABio is a Private company.

  • What is the current valuation of MARABio?

    The current valuation of MARABio is .

  • What is MARABio’s current revenue?

    The current revenue for MARABio is .

  • How much funding has MARABio raised over time?

    MARABio has raised $25.1M.

  • Who are MARABio’s investors?

    MAK Capital, AIF, and Moai Capital have invested in MARABio.

  • Who are MARABio’s competitors?

    LinusBio is a competitor of MARABio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »